Waardenburg syndrome type 1

Waardenburg syndrome type 1 (WS1), also known as Waardenburg syndrome with dystopia canthorum, is a rare genetic disorder affecting the development of neural crest-derived cells. It belongs to a group of conditions collectively called Waardenburg syndrome, which are characterized by varying degrees of sensorineural hearing loss and pigmentary abnormalities of the hair, skin, and eyes. WS1 is specifically distinguished from other types of Waardenburg syndrome by the presence of dystopia canthorum — a lateral displacement of the inner corners (canthi) of the eyes, giving the appearance of a widened nasal bridge. The condition primarily affects the auditory system, skin, hair, and eyes. Key clinical features include congenital sensorineural hearing loss (which may be unilateral or bilateral and ranges from mild to profound), heterochromia iridis (eyes of different colors) or brilliant blue eyes, a white forelock (poliosis) or premature graying of the hair, and patchy depigmentation of the skin (leukoderma). The broad nasal root and dystopia canthorum are hallmark craniofacial features. Not all individuals with WS1 exhibit every feature; the condition shows significant clinical variability even within the same family. Hearing loss is present in approximately 60% of affected individuals. WS1 is caused by pathogenic variants in the PAX3 gene located on chromosome 2q36.1, which plays a critical role in the development and migration of neural crest cells during embryonic development. There is currently no cure for Waardenburg syndrome type 1. Management is primarily supportive and focuses on early identification and treatment of hearing loss through hearing aids or cochlear implants, speech therapy, and regular audiological monitoring. Dermatologic features generally do not require treatment but sun protection is recommended for depigmented skin areas. Genetic counseling is recommended for affected individuals and their families.

Common questions about Waardenburg syndrome type 1